Phase 3 testing confirms HIV fat disorder drug findings
Posted on December 18, 2008
Filed Under 365Gay, News
(Montreal, Quebec) Theratechnologies has concluded a Phase 3 trial confirming earlier clinical results on the safety and effectiveness of its lead drug, tesamorelin, for an HIV-related fat disorder.
Patients lost 18 per cent of their excess visceral fat after 52 weeks of treatment, …
Canadian Drug Company Reports Positive Result On HIV Drug For Fat DisorderMarriage rights enter new phase, ‘Mr. Sulu’ beams
GayWired Confidential: I Survived an Eating Disorder
Calif. gay marriage battle enters final phase
Senate Okays Bill to Require HIV Testing in Prisons
Comments
